We have recently shown that suppressing HLCS expression in both low and highly-invasive breast cancer cell lines, MCF-7 and MDA-MB-231, respectively, inhibits their growth and migration, accompanied by cell cycle arrest, indicating the pro-oncogenic role of HLCS (Siritutsoontorn et al., 2022). The gene discussed is HLCS; the disease is breast carcinoma.